Reagent Kit for Quantitative Detection of HIV-1 RNA in Clinical Samples Using PCR with Hybridization-Fluorescence Detection "AmpliSens® HIV-Monitor-FRT" (TU 9398-008-01897593-2012)

Reagent Kit for Quantitative Detection of HIV-1 RNA in Clinical Samples Using PCR with Hybridization-Fluorescence Detection "AmpliSens® HIV-Monitor-FRT" (TU 9398-008-01897593-2012)

The reagent kit is designed for the quantitative determination of HIV-1 RNA in clinical material.

Detection method: Polymerase Chain Reaction (PCR) with hybridization-fluorescence detection.

Standard compliance: TU 9398-008-01897593-2012.

Available format: FRT

The kit is available in five package configurations:

• Form 1: Includes "RIBO-sorb-12" reagent set and "PCR kit" FRT variant.
• Form 2: Includes "RIBO-prep" variant 50 and "PCR kit" FRT variant.
• Form 4: Includes "MAGNO-sorb" variant 100-1000 and two "PCR kit" FRT variants.
• Form 5: Includes "PCR kit" FRT variant and "HIV-Q Calibration Kit".
• Form 6: Includes "PCR kit" FRT variant.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Quantitative Detection of HIV-1 RNA in Clinical Samples Using PCR with Hybridization-Fluorescence Detection "AmpliSens® HIV-Monitor-FRT" (TU 9398-008-01897593-2012), then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.